Skip to content
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
    • Alliances and Community
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Expanded Access Policy
  • Contact Us
Menu
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
    • Alliances and Community
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Expanded Access Policy
  • Contact Us
Search
Close this search box.
Read more about the article Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

  • Post author:Shahid Ahmad
  • Post published:February 26, 2020
  • Post category:Uncategorized

Coronavirus (COVID-19) kills by inducing Acute Respiratory Distress Syndrome (ARDS). According to a recent article in The Lancet, 12 out of 41 (29%) COVID-19 patients from Wuhan, China developed ARDS…

Continue ReadingVasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

Recent Posts

  • Vasomune Therapeutics Receives US FDA Fast Track Designation for Novel Investigational Medicine AV-001
  • American Thoracic Society Selects Vasomune Therapeutics Inc., to Present the AV-001 Development Update at the 2024 Respiratory Innovation Summit
  • AV-001 Receives Positive Recommendation from the IDSMB for AV001-004 Phase 2a Study
  • Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease
  • Vasomune Announces Government Financial Support for the Development of COVID-19 Therapeutic

Recent Comments

    Archives

    • May 2024
    • April 2024
    • November 2023
    • January 2022
    • November 2021
    • March 2021
    • December 2020
    • November 2020
    • August 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • August 2018
    • December 2017
    • June 2015

    Categories

    • Press Release
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About

    Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying the host vascular endothelial response.

    Vasomune Therapeutics 2025 © All Rights Reserved.